Navigation Links
India extends National TB Control Program

The Indian Cabinet Committee on Economic Affairs has approved to extend by five years the Revised National TB Control Program (RNTBC)to benefit over five million people.//

The extension of the program from Oct 1, 2005 to Sep 30, 2010 would involve an expenditure of Rs.11.56 billion ($255 million). Of this, Rs.2.82 billion would be required in the 10th Plan (2002-07) and Rs.8.73 billion in the 11th Plan (2007-12).

"The direct benefit would be the treatment of 5.32 million TB patients during the project period. Of these, at least 4.52 million patients would be cured," an official spokesperson said Friday.

"This will result in averting at least 960,000 deaths, of which 480,000 would be adults, with an economic output potential of at least Rs.14,000 per year," the official said.

At an average working life of 15 years, this would mean a national economic saving of more than Rs.100 billion.

India is estimated to account for nearly 30 percent of the global tuberculosis burden. The disease is viewed as a major health problem because of its high mortality and morbidity.

RNTCP was introduced in India through a series of pilot projects beginning in 1993. Over the years it has been gradually stepped up to cover a larger population.

In 1997, the World Bank assisted RNTCP was launched at a project cost of Rs.7.49 billion and included a World Bank component of Rs.6.05 billion.

It was targeted to cover a population of 271 million (1991 census) in 102 Short Course Chemotherapy (SCC) districts and strengthen another 203 SCC districts for introduction of RNTCP at a later stage over a period of five years.

The project was further extended up to March 2004 to cover a total population of 700 million.

-- Edited(IANS)
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
(Date:5/15/2008)...iven in conjunction with cancer vaccines may boost...g the effectiveness of this promising type of canc... the Duke Comprehensive Cancer Center. , Chemoth...press immune function and we speculated that this ...junction with vaccines, which work by boosting imm...
(Date:5/15/2008)...ected to enhance service levels and expand ... CITY, South Korea, May 15 /PRNewswire/ -- Today, ...west technical ceramics manufacturing,facility in ...igh-purity,and other specialty ceramics, primarily...l display industries, fueled the additional facili...
(Date:5/15/2008)...wswire/ -- LifeCare Holdings, Inc. (the,"Company")...st quarter,ended March 31, 2008., Net Revenues, ...million, or 7.8%, for,the three months ended March... the comparable period in 2007. Patient days in th...e same period in 2007., The increase in our net p...
(Date:5/15/2008)...ire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT)...chase agreement to,sell the land and building comp...undeveloped parcel of land in Vancouver, British C...ction, QLT will enter into a,five-year lease of sp..."We are very pleased that our strategic efforts to...
Breaking Medicine News(10 mins):Health News:Chemotherapy might help cancer vaccines work 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 2Health News:LifeCare Holdings, Inc. Announces First Quarter Results 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 4Health News:LifeCare Holdings, Inc. Announces First Quarter Results 5Health News:LifeCare Holdings, Inc. Announces First Quarter Results 6Health News:LifeCare Holdings, Inc. Announces First Quarter Results 7Health News:LifeCare Holdings, Inc. Announces First Quarter Results 8Health News:LifeCare Holdings, Inc. Announces First Quarter Results 9Health News:QLT Inc. announces agreement for sale of real estate 2Health News:QLT Inc. announces agreement for sale of real estate 3
...ned Wednesday of sophisticated Asian-based rackets...ousands of people every year//.Dallas Mildenhall s...the proper ingredients to treat illnesses such as ...vents and even remains of insects. Mildenhall, who...
... common crime with studies showing that around one...east once//. These shocking figures were compiled...'s Medical Research Council. Interviews of 1,370 ... revealed about 8 per cent who admitted to sexuall...
...-changing operations unless they agree to kick the...hospitals say that they will not treat patients fo... to give up on smoking. Those who do not stop the ... Smokers are at a big risk of complications and th...
...ealth should not be discouraged from drinking by d... study of nearly 9,000 men in the US showed that//...ack. The studies showed that men who drank around...l every day on average demonstrated nearly a third...
Other Medicine News:Health News:New Zealand Scientist Warns On Fake Drugs 2Health News:Smokers Warned to Give up else Face Denial of Operations 2Health News:Smokers Warned to Give up else Face Denial of Operations 3
(Date:5/14/2008)...pps Florida and Scripps Research in La ... Calif., and LA JOLLA, Calif., May 14 /PRNewswire-...aq: PARD ), a,biopharmaceutical company focused o...non-profit biomedical research organization, today...ensing classes of protein kinase,inhibitors for th...
(Date:5/14/2008)...s advocate to lead expansion of Cytel,s ... CAMBRIDGE, Mass., May 14 /- Cytel I...ervices and specialized statistical software,toda...ice President,Adaptive Trials., Judith Quinlan b...to,the Cytel team. Prior to joining Cytel Judith s...
(Date:5/14/2008)...ire-FirstCall/ -- The Quigley,Corporation (Nasdaq:...onducted by its wholly owned subsidiary, Quigley P...luate the anti-viral activity of its compound,QR44... had been infected,with Infectious Bronchitis Viru...448(a) is efficacious against an IBV challenge in ...
(Date:5/13/2008)...-USNewswire/ -- In women at increased,risk for bre...ion to,routine mammography revealed 28 percent mor...itional ultrasound exam substantially increased th... biopsies, according to an,American College of Rad...the May 14, 2008 issue of the Journal of American ...
Breaking Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Judith Quinlan Joins Cytel as Vice President, Adaptive Trials 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 2Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 3CTG Announces 2008 First Quarter Conference Call and Webcast Information 17120 1CTG Announces 2008 First Quarter Conference Call and Webcast Information 17120 2Ezra Susser MD DrPH receives Distinguished Investigator Award from NARSAD 17118 1Ezra Susser MD DrPH receives Distinguished Investigator Award from NARSAD 17118 2APIC Conference to Address New CMS Regulations 17115 1APIC Conference to Address New CMS Regulations 17115 2MSA Schedules First Quarter Earnings Webcast 17111 1MSA Schedules First Quarter Earnings Webcast 17111 2
...PRNewswire-FirstCall/ --,Phosphagenics Limited (AI...clinical studies of its TPM-02 dermal drug deliver...ing topical,treatment for severe acne and an activ...roof of concept studies showed a three-fold increa...he skin when formulated,with TPM-02 compared to a ...
...re-USNewswire/ -- Childhood,cancers are fortunatel... case, accounting for 7 percent of all childhood c... It typically occurs as a,solid tumor in the abdom...oping in the network of the body,s sympathetic ner...ll a heterogeneous disease;,its name includes subt...
Other Medicine Technology:Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 2Neuroblastoma Expert Reviews Progress and Challenges in Fighting,Difficult Pediatric Cancer 3
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast.
Albumin reagent is used for the quantitative determination of albumin concentration in human serum.
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum.
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Single vial, dry powder reagen
Medicine Products: